November 5, 2015
Meda Launches Part 3 Of The Medikidz Explain Asthma Comic Books
Child using Inhaler

SOMERSET, N.J., Nov. 5, 2015 /PRNewswire/ — Meda Pharmaceuticals (Meda), a leading international specialty pharmaceutical company, announces the launch of Part 3 of the Medikidz Explain Asthma Series, the latest comic book to help families gain an accurate understanding of asthma. Medikidz Explain Asthma Part 3 is the third installment of a series of books developed for children with asthma and their families in collaboration with Medikidz, a global organization that produces unique learning materials for children in a powerfully visual comic book format. It follows Savion, age 10, on an epic journey through Mediland, as he gets a firsthand view of the science behind asthma.

“Our goal for the series is to engage kids and help them better understand and manage their asthma as well as overcome challenges associated with this chronic health condition,” said Stuart Loesch, Senior Vice President of Sales and Marketing, Meda. “We are committed to changing the patient landscape, by providing tools like Medikidz Explain Asthma for physicians to better connect with patients and families.”

Asthma is a common respiratory condition that affects 6.8 million children in the U.S. alone,1 according to the U.S. Centers for Disease Control and Prevention. It is characterized by difficulty breathing, wheezing, coughing and shortness of breath.

Medikidz comic books are written and reviewed by physician specialists to help families gain an accurate understanding of medical information. The action adventure world of its superhero characters helps explain illnesses and treatments to children. The Medikidz Explain Asthma series was developed in partnership with, and endorsed by, leading asthma and healthcare organizations.

“Medikidz Explain Asthma helps kids understand their asthma in a truly unique way, on a level they can understand and relate to. When kids have a better understanding about what’s happening in their body, they begin to approach the way they manage their asthma in a whole new way,” said Autumn Burnette, MD, Assistant Professor in the Division of Allergy and Immunology at Howard University Hospital. “They self-advocate more and become more of a partner in their care along with their healthcare provider. The series is a remarkable tool for educating and empowering kids with chronic asthma.”

Ordering the Comic Books

Healthcare providers can visit to order their copies. Patients and caregivers can request a free copy directly from their provider.

In addition, attendees at the American College of Allergy, Asthma, and Immunology (ACAAI) 2015 Annual Scientific Meeting, held November 5-9, in San Antonio, TX, will get a first look at Medikidz Explain Asthma Part 3 and also have a chance to meet some of the Medikidz firsthand. Copies will be available to registered meeting attendees.

About Meda Pharmaceuticals

Meda is a leading international specialty pharma company with a broad product portfolio and its own sales organizations in almost 60 countries. Including those markets where sales are managed by distributors, Meda’s products are sold in more than 120 different countries. Meda’s product portfolio is divided into three main areas: specialty products, OTCs (nonprescription products and dietary supplements) and branded generics. In the United States, Meda has a strong history in respiratory innovation, with a focus in allergy and asthma.

Jumo Health develops age-appropriate, culturally relevant, and relatable educational resources for patients and caregivers. We have experience serving diverse populations, covering more than 160 health topics across 80+ countries in 120+ languages. Our various digital, video, and print offerings use highly visual elements and research-backed health literacy strategies to ensure that everyone can understand and act upon complex medical information. We do this through familiar mediums – from comic books and animation, to virtual reality experiences and authentic documentary-style patient stories – all customized based on audience. Jumo Health collaborates globally with more than 180 advocacy groups and community organizations to promote access and to ensure unique patient experiences are accurately represented.

Media contact

For more information about Jumo Health or this article, contact Dani Himelright by calling +1 (614) 284-6804 or emailing

It looks like you're using an outdated browser. Please upgrade your browser for the best experience.